Supporting evidence

• LedgerRevenue +10% YoY (Q4 FY2026)
• LedgerMixed quarter based on: Strategic recapitalization with MTL Cannabis Corp. is the dominant theme, signaling corporate restructuring focus · 43% and 24% YoY growth metrics present but lack sufficient c…
• GuidanceGuidance maintained

• LedgerRevenue +10% YoY (Q4 FY2026)
• EventNeutral Management Tone
• EventGuidance Unchanged
• EventStrategic Recapitalization Underway
• EventNo impact on revenue, gross margin, operating income/loss, cash flows, Adjusted EBITDA, total assets, cash balances, liquidity, debt covenants, or borrowing capacity.
• EventStrengthened market position in Canadian medical cannabis.
• EventThe error is non-cash and does not impact revenue, gross margin, operating income/loss, cash flows, Adjusted EBITDA, total assets, cash balances, liquidity, or compliance with debt…
• InitiativeEstablished over the past year and continued into fiscal 2027.
• InitiativeMade in fiscal 2026.
• InitiativeLaid in fiscal 2026.
• InitiativeThe acquisition of MTL Cannabis is intended to support this objective, and the company reported a 17% reduction in Adjusted EBITDA loss for Q3 FY2026.
• EventLimited financial disclosure reduces visibility into actual revenue and EPS performance
• EventIntegration risk associated with MTL Cannabis Corp. recapitalization transactions